Kalytera Announces Binding Agreement to Acquire Salzman Group
Hit enter to search or ESC to close
Kalytera Therapeutics, Inc.
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact
Media Mentions

DEA: Marijuana remains a schedule I controlled substance [NNBW]

By Kalytera August 29, 2016 No Comments

DEA: Marijuana remains a schedule I controlled substance [NNBW]

http://www.nnbw.com/news/23595334-113/dea-marijuana-remains-a-schedule-i-controlled-substance
Get Email Alerts Subscribe

New Website Coming Soon


© 2020 Kalytera Therapeutics, Inc.

Kalytera Announces Binding Agreement to Acquire Salzman Group
  • Investors
    • Investor Overview
    • Press Releases
    • Company Information
    • SEDAR Filings
    • SEC Filings
    • Stock Information
    • Corporate Governance
  • Contact

© 2016 Kalytera Therapeutics, Inc.